Skip to main content
Stuart Seropian, MD, Oncology, New Haven, CT

Stuart E Seropian MD

Hematologic Oncology


Associate Professor, Comprehensive Cancer Center, Yale University School of Medicine

Join to View Full Profile
  • 800 Howard AveBldgNew Haven, CT 06519

  • Phone+1 203-785-4191

  • Fax+1 203-737-2617

Dr. Seropian is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 1994 - 1997
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Internal Medicine, 1991 - 1994
  • George Washington University School of Medicine and Health Sciences
    George Washington University School of Medicine and Health SciencesClass of 1991

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 1997 - 2025
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Peripheral Blood Involvement By Flow Cytometry As a Prognostic Factor in Aggressive T Cell Lymphomas Following Autologous Stem Cell Transplantation
    Stuart Seropian, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Immune Checkpoint Inhibitor Therapy for Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndromes: A Single-Center Experience
    Stuart Seropian, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

  • What Does It Mean to Be ‘Immunocompromised’?
    What Does It Mean to Be ‘Immunocompromised’?October 18th, 2021
  • Life Expectancy Still Lower for Blood or Marrow Transplant Recipients
    Life Expectancy Still Lower for Blood or Marrow Transplant RecipientsSeptember 9th, 2021
  • Yale Cancer Center Earns International Reaccreditation for Expertise in CAR T-cell Therapy and Stem Cell Transplantation
    Yale Cancer Center Earns International Reaccreditation for Expertise in CAR T-cell Therapy and Stem Cell TransplantationMay 9th, 2024

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: